Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Elucidating the Interplay Between DDX41 and CUX1 Mutations in Hematopoiesis in Danio Rerio and iPSCs

Award Number: F31HL178296
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 12/01/2024
PERIOD OF PERFORMANCE END DATE: 03/31/2028

Group Awards By:

View Award Description

Elucidating the Interplay Between DDX41 and CUX1 Mutations in Hematopoiesis in Danio Rerio and iPSCs - PROJECT SUMMARY Myelodysplastic syndromes (MDS) are a family of bone marrow failure disorders involving defective hematopoietic stem and progenitor cells (HSPCs). In MDS, there is clonal expansion of defective HSPCs over healthy cells, ineffective maturation and uni- or multilineage cytopenias of myeloid lineage cells, and increased risk of transformation to acute myeloid leukemia (AML). Although the field recognizes the effects of MDS, the origins and evolution of its pathogenesis are incompletely understood. Somatic and germline mutations contribute to MDS/AML formation by altering HSPC proliferation, differentiation, and survival. Heterozygous germline mutations of DEAD-box helicase 41 (DDX41) predispose individuals to hematologic malignancies, especially MDS/AML. Despite carrying the mutation throughout life, patients typically do not develop MDS until later in adulthood, which suggests secondary factors play key roles in driving disease. Researchers identified a strong enrichment for co-occurrence mutations in DDX41 and CUT-like homeobox 1 (CUX1), which encodes for a nonclustered homeodomain transcription factor and tumor suppressor gene and may act as a secondary somatic driver mutation in DDX41 patients. My project aims to delineate how co- occurring ddx41 and cux1 mutations cooperate to drive hematopoietic dysfunction using zebrafish and human induced pluripotent stem cells (iPSCs). In vivo, in zebrafish, I will characterize the blood system during embryogenesis by assessing changes in HSPCs, and differentiated progeny, including erythroid cells. In adult zebrafish, I will evaluate if mutations in cux1 paralogs accelerate or exacerbate hematopoietic decline and assess changes in age-associated clonal HSPC expansion, using Zebrabow, a novel method that utilizes a Cre- lox system to induce a heritable color barcoding unique to each HSPC and its progeny. To determine if our findings are conserved in humans, I will also assess HSPC levels and hematopoietic differentiation into erythrocytes in human iPSCs with a common germline DDX41 mutation in combination with CUX1 mutagenesis. These experiments will provide mechanistic insight into how these common co-occurring mutations might drive hematopoietic dysfunction and ultimately contribute to the development of MDS/AML.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $55,114 )
2026	2026	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Blood Diseases and Resources Research	000	2	1/31/2026	NON-COMPETING CONTINUATION	$54,538
2026	2026	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Blood Diseases and Resources Research	001	2	5/5/2026	NON-COMPETING CONTINUATION	$576
														Subtotal = $55,114

Issue Date FY: 2025 ( Subtotal = $54,538 )
2025	2025	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Blood Diseases and Resources Research	002	1	1/9/2025	NEW	$0
2025	2025	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Blood Diseases and Resources Research	000	1	1/9/2025	NEW	$53,974
2025	2025	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Blood Diseases and Resources Research	003	1	9/16/2025	NEW	$564
2025	2025	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Blood Diseases and Resources Research	001	1	1/9/2025	NEW	$0
														Subtotal = $54,538

Grand Total All Awards = $109,652

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Elucidating the Interplay Between DDX41 and CUX1 Mutations in Hematopoiesis in Danio Rerio and iPSCs

Award Number: F31HL178296

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 12/01/2024

PERIOD OF PERFORMANCE END DATE: 03/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer